What Researchers Did
Researchers coadministered Doxil with hyperbaric oxygen (HBO) therapy to assess the safety and efficacy of this combination treatment in solid tumors.
What They Found
They found that hyperbaric oxygen (HBO) therapy improved Doxil tumor penetration and sensitized tumor cells by overcoming hypoxia. This combination synergistically inhibited H22 tumor growth with a remarkable 91.5% inhibition rate. Importantly, the combined treatment showed no additional side effects or promotion of tumor metastasis.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation is that this was a preclinical study, and further human clinical trials are needed to confirm these findings.